688139 海尔生物
已收盘 06-18 15:00:01
资讯
新帖
简况
每周股票复盘:XD海尔生(688139)鸿鹄航空拟增资扩股引入新投资者
证券之星 · 06-20 02:51
每周股票复盘:XD海尔生(688139)鸿鹄航空拟增资扩股引入新投资者
股市必读:海尔生物(688139)6月16日董秘有最新回复
证券之星 · 06-17
股市必读:海尔生物(688139)6月16日董秘有最新回复
海尔生物(688139)披露控股子公司增资扩股暨关联交易公告,6月16日股价上涨0.07%
证券之星 · 06-16
海尔生物(688139)披露控股子公司增资扩股暨关联交易公告,6月16日股价上涨0.07%
海尔生物:公司超速离心机于今年上市
证券之星 · 06-16
海尔生物:公司超速离心机于今年上市
海尔生物:公司实控人的一致行动人青岛海创智管理咨询企业(有限合伙)已三次增持公司股票
证券之星 · 06-16
海尔生物:公司实控人的一致行动人青岛海创智管理咨询企业(有限合伙)已三次增持公司股票
每周股票复盘:海尔生物(688139)股东户数降6.61%,海外重点国家收入增超30%
证券之星 · 06-14
每周股票复盘:海尔生物(688139)股东户数降6.61%,海外重点国家收入增超30%
海尔生物:第二季度公司利润预计同比大幅增长
证券之星 · 06-10
海尔生物:第二季度公司利润预计同比大幅增长
海尔生物:已构建“大模型-智能体-智能终端”多层次 AI 架构
证券之星 · 06-10
海尔生物:已构建“大模型-智能体-智能终端”多层次 AI 架构
【机构调研记录】新华基金调研海尔生物
证券之星 · 06-09
【机构调研记录】新华基金调研海尔生物
低温技术跨界突破!海尔生物旗下鸿鹄航空获A轮7000万融资
证券之星 · 06-04
低温技术跨界突破!海尔生物旗下鸿鹄航空获A轮7000万融资
海尔生物:利润端有望在2026年迎来拐点
证券之星 · 06-03
海尔生物:利润端有望在2026年迎来拐点
海尔生物:2025年举办或参与业绩说明会3次
证券之星 · 06-03
海尔生物:2025年举办或参与业绩说明会3次
【机构调研记录】招商基金调研海尔生物、皓元医药
证券之星 · 06-03
【机构调研记录】招商基金调研海尔生物、皓元医药
每周股票复盘:海尔生物(688139)股东户数增2.18%至1.4万户
证券之星 · 05-31
每周股票复盘:海尔生物(688139)股东户数增2.18%至1.4万户
海尔生物新注册《细胞制备全流程追溯系统V2.0》项目的软件著作权
证券之星 · 05-29
海尔生物新注册《细胞制备全流程追溯系统V2.0》项目的软件著作权
5月28日海尔生物跌5.44%,互联网医疗LOF基金重仓该股
证券之星 · 05-28
5月28日海尔生物跌5.44%,互联网医疗LOF基金重仓该股
海尔生物(688139)5月20日股东户数1.4万户,较上期增加2.18%
证券之星 · 05-25
海尔生物(688139)5月20日股东户数1.4万户,较上期增加2.18%
股市必读:5月22日海尔生物发布公告,股东减持237.5万股
证券之星 · 05-25
股市必读:5月22日海尔生物发布公告,股东减持237.5万股
每周股票复盘:海尔生物(688139)股东减持0.75%股份至9.39%
证券之星 · 05-24
每周股票复盘:海尔生物(688139)股东减持0.75%股份至9.39%
5月22日海尔生物发布公告,股东减持237.5万股
证券之星 · 05-22
5月22日海尔生物发布公告,股东减持237.5万股
暂无数据
公司概况
公司名称:
青岛海尔生物医疗股份有限公司
所属行业:
专用设备制造业
上市日期:
2019-10-25
主营业务:
青岛海尔生物医疗股份有限公司的主营业务是针对样本、药品、疫苗、血液等生物对象,提供涵盖-196°C至8°C全温域、软硬服一体化的生物安全解决方案。公司的主要产品是智慧实验室制药工艺、数字医院、智慧公共卫生、智慧用血。报告期内,公司低温存储技术持续领先,依托制冷平台,通过持续优化制冷系统设计、温湿控制和节能技术等核心模块,在极致稳定、绿色效能方向上构筑起代际领先优势。
发行价格:
15.53
{"stockData":{"symbol":"688139","market":"SH","secType":"STK","nameCN":"海尔生物","latestPrice":26.67,"timestamp":1781766001000,"preClose":26.67,"halted":0,"volume":2710152,"delay":0,"changeRate":0,"floatShares":316000000,"shares":316000000,"eps":0.695,"marketStatus":"已收盘","change":0,"latestTime":"06-18 15:00:01","open":26.68,"high":27.19,"low":26.46,"amount":72684900,"amplitude":0.0274,"askPrice":26.68,"askSize":3,"bidPrice":26.67,"bidSize":253,"shortable":0,"etf":0,"ttmEps":0.695,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782091800000},"marketStatusCode":5,"adr":0,"adjPreClose":26.67,"symbolType":"stock_kcb","openAndCloseTimeList":[[1781746200000,1781753400000],[1781758800000,1781766000000]],"highLimit":29.34,"lowLimit":24,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":316492922,"isCdr":false,"pbRate":1.9,"roa":"--","peRate":38.374101,"roe":"1.8%","epsLYR":0.8,"committee":-0.049942,"marketValue":8441000000,"turnoverRate":0.0086,"status":2,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-06-22。","afterMarket":{"amount":0,"volume":0,"close":26.67,"buyVolume":0,"sellVolume":0,"time":1781768037746,"indexStatus":"已收盘 06-18 15:30:00","preClose":26.67},"floatMarketCap":8441000000},"requestUrl":"/m/hq/s/688139/tweets","defaultTab":"tweets","newsList":[{"id":"2644065565","title":"每周股票复盘:XD海尔生(688139)鸿鹄航空拟增资扩股引入新投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2644065565","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644065565?lang=zh_cn&edition=full","pubTime":"2026-06-20 02:51","pubTimestamp":1781895069,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,XD海尔生报收于26.67元,较上周的27.07元下跌1.48%。本周,XD海尔生6月16日盘中最高价报27.36元。XD海尔生当前最新总市值84.41亿元,在医疗器械板块市值排名35/129,在两市A股市值排名2234/5206。本周关注点公司公告汇总:鸿鹄航空拟增资扩股,引入安徽徽海启明创业投资基金和兰溪聚创创业投资作为投资方。增资完成后,鸿鹄航空注册资本由3,750万元增至4,625万元,公司持股比例由72%降至58.38%,鸿鹄航空仍为公司控股子公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000000898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","01169","688139","02252","BK1617","LU2488822045.USD","159231","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644776098","title":"股市必读:海尔生物(688139)6月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2644776098","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644776098?lang=zh_cn&edition=full","pubTime":"2026-06-17 04:28","pubTimestamp":1781641693,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘,海尔生物报收于27.1元,上涨0.07%,换手率1.03%,成交量3.27万手,成交额8753.46万元。公司公告汇总:海尔生物控股子公司鸿鹄航空拟增资扩股,引入两家关联方投资共7,000万元,公司放弃优先认购权,持股比例由72%降至58.38%,仍保持控股地位;该关联交易需提交股东会审议。因投资方与公司同受海尔集团公司控制,本次交易构成关联交易,需提交股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700003748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643598737","title":"海尔生物(688139)披露控股子公司增资扩股暨关联交易公告,6月16日股价上涨0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643598737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643598737?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:45","pubTimestamp":1781606716,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘,海尔生物报收于27.1元,较前一交易日上涨0.07%,最新总市值为85.77亿元。该股当日开盘27.01元,最高27.36元,最低26.33元,成交额达8753.46万元,换手率为1.03%。海尔生物放弃本次增资的优先认购权。增资完成后,鸿鹄航空注册资本由3,750万元增至4,625万元,公司持股比例由72%降至58.38%,鸿鹄航空仍为公司控股子公司。因投资方与公司同受海尔集团公司控制,本次交易构成关联交易,需提交股东会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600036539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643755009","title":"海尔生物:公司超速离心机于今年上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2643755009","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643755009?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:21","pubTimestamp":1781605303,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物(688139)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司研发的国内首台10万转离心机销售情况如何?海尔生物回复:尊敬的投资者您好,作为分离、纯化和分析病毒、蛋白质、核酸、外泌体等生物大分子或亚细胞结构的关键设备,公司超速离心机于今年上市,目前处于市场导入期,已经有多家生物科技企业、研究所等用户订单录入,预计自明年起逐渐进入规模化放量阶段。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600033695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643675570","title":"海尔生物:公司实控人的一致行动人青岛海创智管理咨询企业(有限合伙)已三次增持公司股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2643675570","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643675570?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:21","pubTimestamp":1781605302,"startTime":"0","endTime":"0","summary":"另一方面,运用现金分红、投资者关系管理、信息披露、股份回购等各种方式,提升公司的投资价值和股东回报能力,自上市以来,公司已连续7年实施分红,累计分红8.91亿元人民币,其中2025年年度现金分红将于6月18日发放;公司实控人的一致行动人青岛海创智管理咨询企业已三次增持公司股票,累计增持金额约3.84亿元;公司自身共推出了三轮股份回购计划,累计回购金额共计约2.5亿元,并于2026年1月6日注销部分已回购股份145.96万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600033693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643217906","title":"每周股票复盘:海尔生物(688139)股东户数降6.61%,海外重点国家收入增超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643217906","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643217906?lang=zh_cn&edition=full","pubTime":"2026-06-14 01:26","pubTimestamp":1781371572,"startTime":"0","endTime":"0","summary":"截至2026年6月12日收盘,海尔生物报收于27.07元,较上周的29.82元下跌9.22%。本周,海尔生物6月8日盘中最高价报30.19元。来自机构调研要点:2026年一季度,公司锁定的24个重点国家合计收入增幅超30%。股本股东变化截至2026年6月10日,公司股东户数为1.4万户,较5月31日减少988户,减幅6.61%。户均持股数量由上期的2.12万股升至2.27万股,户均持股市值为60.52万元。相关进展将依规履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061400000244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642144480","title":"海尔生物:第二季度公司利润预计同比大幅增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2642144480","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642144480?lang=zh_cn&edition=full","pubTime":"2026-06-10 16:55","pubTimestamp":1781081709,"startTime":"0","endTime":"0","summary":"针对近期股价大幅下挫、引发市场关注的情况,海尔生物日前在投资者互动平台作出回应,明确表示公司生产经营一切正常,不存在应披露而未披露的重大不利因素。利润方面,第二季度利润预计同比大幅增长,上半年利润端将出现拐点,下半年利润增幅有望进一步高于上半年,全力兑现“利润端在2026年迎来拐点”的指引。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026061000029742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642944510","title":"海尔生物:已构建“大模型-智能体-智能终端”多层次 AI 架构","url":"https://stock-news.laohu8.com/highlight/detail?id=2642944510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642944510?lang=zh_cn&edition=full","pubTime":"2026-06-10 15:37","pubTimestamp":1781077047,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物06月10日在投资者关系平台上答复投资者关心的问题。2025年,公司AI相关收入占整体收入比重达15%,较2024年提升2.5个百分点,场景方案订单同比增长超50%。此外,为进一步向AI+全链路一体化发展,公司设立上海自主实验室合作创新工场,汇聚创新资源,携手阿里云智能、中国信息协会具身智能专业委员会,共同签署《“AI自主实验室”共创生态合作协议》,驱动AI与生命科学深度融合。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000022339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642743016","title":"【机构调研记录】新华基金调研海尔生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2642743016","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642743016?lang=zh_cn&edition=full","pubTime":"2026-06-09 08:11","pubTimestamp":1780963884,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及6月8日披露的机构调研信息,新华基金近期对1家上市公司进行了调研,相关名单如下:1)海尔生物 个股亮点:公司基于高质量数据集打造了盈康大脑基础大模型,聚焦公司四大产业以及多个场景。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900005353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640151910","title":"低温技术跨界突破!海尔生物旗下鸿鹄航空获A轮7000万融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2640151910","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640151910?lang=zh_cn&edition=full","pubTime":"2026-06-04 18:43","pubTimestamp":1780569798,"startTime":"0","endTime":"0","summary":"6月4日,海尔生物发布公告,旗下子公司青岛鸿鹄航空科技有限公司获得A轮7000万元融资,其中关联方徽海启明出资5000万元,非关联方兰溪聚创出资2000万元,本轮融资投前估值3亿元,较鸿鹄航空近期净资产溢价逾15倍。鸿鹄航空的破局与成长,是海尔生物底层低温技术能力向航空冷链产业的系统性迁移。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026060400034677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1617","688139","02252","LU2488822045.USD","BK1100","159231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640908447","title":"海尔生物:利润端有望在2026年迎来拐点","url":"https://stock-news.laohu8.com/highlight/detail?id=2640908447","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640908447?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:48","pubTimestamp":1780480124,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物06月03日在投资者关系平台上答复投资者关心的问题。投资者提问:公司股价连跌5年,同期大盘已经连涨3年了,公司所处于的科创板也处于大牛市当中,人心都是肉涨的,你们真的应该向广大投资者道歉海尔生物回复:尊敬的投资者您好,二级市场股价波动受宏观经济、行业周期、市场情绪等多重因素影响,未必能及时、全面地体现公司的内在价值与发展趋势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300036639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640908243","title":"海尔生物:2025年举办或参与业绩说明会3次","url":"https://stock-news.laohu8.com/highlight/detail?id=2640908243","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640908243?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:48","pubTimestamp":1780480097,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物06月03日在投资者关系平台上答复投资者关心的问题。2025年公司举办或参与业绩说明会3次、集体接待日活动1次,发布《投资者关系记录表》27篇,回复e互动问题107个,发布《可持续发展报告》中英文版,不断满足海内外各类投资者的多元化需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300036626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640243939","title":"【机构调研记录】招商基金调研海尔生物、皓元医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2640243939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640243939?lang=zh_cn&edition=full","pubTime":"2026-06-03 08:01","pubTimestamp":1780444891,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及6月2日披露的机构调研信息,招商基金近期对2家上市公司进行了调研,相关名单如下:1)海尔生物 调研纪要:2026年一季度公司实现营业收入6.52亿元,归母净利润0.79亿,归母净利润率较2025年提升1.42个百分点。国内业务连续三个季度环比增长,海外剔除欧洲高基数影响后同比增长26%。智慧用药产业受欧洲项目交付影响收入下滑16%,但在手订单增幅超50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300008250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688131","688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639049836","title":"每周股票复盘:海尔生物(688139)股东户数增2.18%至1.4万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2639049836","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639049836?lang=zh_cn&edition=full","pubTime":"2026-05-31 03:23","pubTimestamp":1780168989,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,海尔生物报收于31.46元,较上周的36.79元下跌14.49%。本周,海尔生物5月25日盘中最高价报38.0元。海尔生物当前最新总市值99.57亿元,在医疗器械板块市值排名30/129,在两市A股市值排名1991/5207。户均持股数量由上期的2.31万股减少至2.26万股,户均持股市值为75.04万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639618558","title":"海尔生物新注册《细胞制备全流程追溯系统V2.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2639618558","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639618558?lang=zh_cn&edition=full","pubTime":"2026-05-29 01:59","pubTimestamp":1779991151,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物(688139)新注册了《细胞制备全流程追溯系统V2.0》项目的软件著作权。今年以来海尔生物新注册软件著作权11个,较去年同期减少了15.38%。结合公司2025年年报财务数据,2025年公司在研发方面投入了3.23亿元,同比增5.58%。通过天眼查大数据分析,青岛海尔生物医疗股份有限公司共对外投资了17家企业,参与招投标项目3500次;财产线索方面有商标信息607条,专利信息1966条,著作权信息144条;此外企业还拥有行政许可46个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900001882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","159180","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638651206","title":"5月28日海尔生物跌5.44%,互联网医疗LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638651206","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638651206?lang=zh_cn&edition=full","pubTime":"2026-05-28 16:32","pubTimestamp":1779957167,"startTime":"0","endTime":"0","summary":"证券之星消息,5月28日海尔生物跌5.44%,收盘报32.17元,换手率2.74%,成交量8.66万手,成交额2.83亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为汇添富基金的互联网医疗LOF。互联网医疗LOF的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800028959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251","501007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638253139","title":"海尔生物(688139)5月20日股东户数1.4万户,较上期增加2.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638253139","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638253139?lang=zh_cn&edition=full","pubTime":"2026-05-25 17:29","pubTimestamp":1779701390,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物披露,截至2026年5月20日公司股东户数为1.4万户,较5月8日增加299.0户,增幅为2.18%。在医疗器械行业个股中,海尔生物股东户数低于行业平均水平,截至5月20日,医疗器械行业平均股东户数为2.21万户。从股价来看,2026年5月8日至2026年5月20日,海尔生物区间涨幅为4.46%,在此期间股东户数增加299.0户,增幅为2.18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500024463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638011723","title":"股市必读:5月22日海尔生物发布公告,股东减持237.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638011723","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638011723?lang=zh_cn&edition=full","pubTime":"2026-05-25 01:02","pubTimestamp":1779642138,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,海尔生物报收于36.79元,上涨10.81%,换手率6.76%,成交量21.39万手,成交额7.7亿元。来自股本股东变化:股东青岛海创睿于5月15日至22日减持237.5万股,持股比例由10.14%降至9.39%。海尔生物持股5%以上股东权益变动触及1%刻度、提前终止减持计划暨减持股份结果公告青岛海创睿股权投资基金中心持有海尔生物32,103,659股,占总股本10.14%。截至2026年5月22日,累计减持2,375,000股,占总股本0.75%,减持后持股比例降至9.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500000452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637787443","title":"每周股票复盘:海尔生物(688139)股东减持0.75%股份至9.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637787443","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637787443?lang=zh_cn&edition=full","pubTime":"2026-05-24 01:50","pubTimestamp":1779558624,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,海尔生物报收于36.79元,较上周的33.96元上涨8.33%。海尔生物持股5%以上股东权益变动触及1%刻度、提前终止减持计划暨减持股份结果公告青岛海创睿股权投资基金中心持有海尔生物32,103,659股,占总股本10.14%。因自身资金需求,海创睿原计划减持不超过0.85%股份。截至2026年5月22日,累计减持2,375,000股,占总股本0.75%,减持后持股比例降至9.39%。实际控制人及其一致行动人合计持股比例由44.67%降至43.92%,权益变动触及1%刻度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637798348","title":"5月22日海尔生物发布公告,股东减持237.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637798348","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637798348?lang=zh_cn&edition=full","pubTime":"2026-05-22 23:01","pubTimestamp":1779462062,"startTime":"0","endTime":"0","summary":"证券之星消息,5月22日海尔生物发布公告《海尔生物:海尔生物持股5%以上股东权益变动触及1%刻度、提前终止减持计划暨减持股份结果公告》,其股东青岛海创睿股权投资基金中心(有限合伙)于2026年5月15日至2026年5月22日间合计减持237.5万股,占公司目前总股本的0.7504%,变动期间该股股价上涨10.15%,截止5月22日收盘报36.79元。股东增减持详情见下表:根据海尔生物2026年一季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200045683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782037784285,"stockEarnings":[{"period":"1week","weight":0.0225},{"period":"1month","weight":-0.1937},{"period":"3month","weight":-0.1527},{"period":"6month","weight":-0.1438},{"period":"1year","weight":-0.1085},{"period":"ytd","weight":-0.1506}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":-0.019},{"period":"3month","weight":0.0337},{"period":"6month","weight":0.0514},{"period":"1year","weight":0.2071},{"period":"ytd","weight":0.0306}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"青岛海尔生物医疗股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"13953人(较上一季度减少6.61%)","perCapita":"22682股","listingDate":"2019-10-25","address":"山东省青岛市城阳区高新区丰源路280号","registeredCapital":"31649万元","survey":" 青岛海尔生物医疗股份有限公司的主营业务是针对样本、药品、疫苗、血液等生物对象,提供涵盖-196°C至8°C全温域、软硬服一体化的生物安全解决方案。公司的主要产品是智慧实验室制药工艺、数字医院、智慧公共卫生、智慧用血。报告期内,公司低温存储技术持续领先,依托制冷平台,通过持续优化制冷系统设计、温湿控制和节能技术等核心模块,在极致稳定、绿色效能方向上构筑起代际领先优势。","listedPrice":15.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海尔生物,688139,海尔生物股票,海尔生物股票老虎,海尔生物股票老虎国际,海尔生物行情,海尔生物股票行情,海尔生物股价,海尔生物股市,海尔生物股票价格,海尔生物股票交易,海尔生物股票购买,海尔生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}